Sangiovanni A - Search Results

1

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma.

Moshiri F, Salvi A, Gramantieri L, Sangiovanni A, Guerriero P, De Petro G, Bassi C, Lupini L, Sattari A, Cheung D, Veneziano D, Nigita G, Shankaraiah RC, Portolani N, Carcoforo P, Fornari F, Bolondi L, Frassoldati A, Sabbioni S, Colombo M, Croce CM, Negrini M. Moshiri F, et al. Among authors: sangiovanni a. Oncotarget. 2018 Feb 27;9(20):15350-15364. doi: 10.18632/oncotarget.24601. eCollection 2018 Mar 16. Oncotarget. 2018. PMID: 29632649 Free PMC article.

2

The natural history of hepatocellular carcinoma.

Colombo M, Sangiovanni A. Colombo M, et al. Among authors: sangiovanni a. Ital J Gastroenterol. 1992 Feb;24(2):95-9. Ital J Gastroenterol. 1992. PMID: 1315595 Review.

3

Hepatitis C virus and hepatocellular carcinoma.

Sangiovanni A, Covini G, Rumi MG, Marcelli R, Colombo M. Sangiovanni A, et al. Arch Virol Suppl. 1992;4:70-5. doi: 10.1007/978-3-7091-5633-9_15. Arch Virol Suppl. 1992. PMID: 1333332 Review.

4

Hepatocellular carcinoma in Italian patients with cirrhosis.

Colombo M, de Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, Donato MF, Piva A, Di Carlo V, Dioguardi N. Colombo M, et al. Among authors: sangiovanni a. N Engl J Med. 1991 Sep 5;325(10):675-80. doi: 10.1056/NEJM199109053251002. N Engl J Med. 1991. PMID: 1651452 Free article.

5

Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial.

Colombo M, de Franchis R, Tommasini M, Sangiovanni A, Dioguardi N. Colombo M, et al. Among authors: sangiovanni a. Hepatology. 1989 Mar;9(3):433-8. doi: 10.1002/hep.1840090315. Hepatology. 1989. PMID: 2563985 Clinical Trial.

6

Beta-blockers in the secondary prevention of gastrointestinal haemorrhage in well-compensated cirrhotics. A multicentre randomised controlled study.

Tommasini M, de Franchis R, Sangiovanni A, Colombo M. Tommasini M, et al. Among authors: sangiovanni a. Drugs. 1989;37 Suppl 2:35-41; discussion 47. doi: 10.2165/00003495-198900372-00007. Drugs. 1989. PMID: 2572412 Clinical Trial.

7

High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.

Fasani P, Sangiovanni A, De Fazio C, Borzio M, Bruno S, Ronchi G, Del Ninno E, Colombo M. Fasani P, et al. Among authors: sangiovanni a. Hepatology. 1999 Jun;29(6):1704-7. doi: 10.1002/hep.510290604. Hepatology. 1999. PMID: 10347111

8

The European approach to hepatocellular carcinoma.

Colombo M, Sangiovanni A. Colombo M, et al. Among authors: sangiovanni a. Hepatogastroenterology. 2002 Jan-Feb;49(43):12-6. Hepatogastroenterology. 2002. PMID: 11941934 Review.

9

Segmental transcatheter arterial chemoembolization treatment in patients with cirrhosis and inoperable hepatocellular carcinomas.

Saccheri S, Lovaria A, Sangiovanni A, Nicolini A, De Fazio C, Ronchi G, Fasani P, Del Ninno E, Colombo M. Saccheri S, et al. Among authors: sangiovanni a. J Vasc Interv Radiol. 2002 Oct;13(10):995-9. doi: 10.1016/s1051-0443(07)61863-6. J Vasc Interv Radiol. 2002. PMID: 12397120 Clinical Trial.

10

Etiology, natural history and treatment of hepatocellular carcinoma.

Colombo M, Sangiovanni A. Colombo M, et al. Among authors: sangiovanni a. Antiviral Res. 2003 Oct;60(2):145-50. doi: 10.1016/j.antiviral.2003.08.010. Antiviral Res. 2003. PMID: 14638411 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page